FLEX Monoclonal Rabbitt Anti-Human Estrogen Receptor a, Clone EP1, Ready-to-Use (Link); FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 636, Ready-to-Use (Link)
FDA 510(k) clearance K160922 · decided 2016-05-03
Clearance details
- K-number
- K160922
- Device name
- FLEX Monoclonal Rabbitt Anti-Human Estrogen Receptor a, Clone EP1, Ready-to-Use (Link); FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 636, Ready-to-Use (Link)
- Applicant
- Dako North America, Inc.
- Decision
- Substantially Equivalent
- Date received
- 2016-04-04
- Decision date
- 2016-05-03
- Days to decision
- 29 days
- Clearance type
- Special
- Product code
- MXZ
- Device class
- 2
- Regulation number
- 864.1860
- Medical specialty
- Hematology
- Advisory committee
- Hematology
- Location
- Carpinteria, CA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Dako North America
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
Recalls involving this device
No recalls on record reference this clearance.
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| C-Kit pharmDx (P040011/S003) | Dako North America, Inc. | 2017-05-16 |
| PD-L1 IHC NIVOLUMAB PHARMDX (P150027/S004) | Dako North America, Inc. | 2017-03-24 |
| PD-L1 IHC 28-8 PHARMDX (P150027/S003) | Dako North America, Inc. | 2017-02-24 |
| PD-L1 IHC 28-8 PHARMDX (Melanoma Indication) (P150027/S002) | Dako North America, Inc. | 2016-12-01 |
| PD-L1 IHC 28-8 PHARMDX (MELANOMA INDICATION) (P150027/S001) | Dako North America, Inc. | 2016-10-05 |
| PD-L1 IHC 28-8 pharmDx (P150027) | Dako North America, Inc. | 2016-01-23 |
| C-KIT PHARMDX (P040011/S002) | Dako North America, Inc. | 2012-11-02 |
| DAKO C-KIT PHARMDX (P040011/S001) | Dako North America, Inc. | 2007-04-23 |